ProCE Banner Activity

Connected Insulin Pens: Improving Type 1 and 2 Diabetes Management

Clinical Thought
Learn how the features of connected insulin pens could help you optimize the care of your diabetes patients.

Released: February 15, 2022

Expiration: February 14, 2023

No longer available for credit.

Share

Faculty

Diana Isaacs

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator

Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by the Endocrine Society, in collaboration with Clinical Care Options.
ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk Inc

Faculty Disclosure

Primary Author

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator

Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, has disclosed that she has received consulting fees from Abbott, Dexcom, Insulet, Lilly, Medtronic, and Novo Nordisk.